With the advance of therapeutic technique and treatment technology as well as aging society in Thailand, public healthcare budget is rising year by year. Hospitals also need more money to cope with the rise in hospital visits, which are soon expected to reach 6 million cases a year. Considering the demographic movement and disease aspect change in Thailand, in order to realize sustainable healthcare system, it is more than likely that medicines with better cost benefit performance for unmet medical needs will be more useful and helpful.
Daiichi-Sankyo has a long history for creating innovative pharmaceuticals via R&D activities and has received economic awards for the value we deliver by providing these pharmaceuticals to people around the world. We will continuously devote ourselves to deliver innovative medicines, which can change standard of care, to those who really need them.
DaiichiSankyo has company mission that is to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.
And one of our visions is to have enriched regional value products aligned with regional market. Regional value products mean products being aligned with regional market needs.
DaiichiSankyo (Thailand) Ltd. has more than 20 years business history in Thailand focusing mainly to infectious, cardiovascular and pain field. Through our products we are covering many therapeutic fields such as CC, IC, EP, IM, Endocrinologist, Nephrologist, Neurologist, GP, FM, Infection, ENT, Pulmonologist, Surgeon, Orthopedist, GI, Ophthalmologist, Hematologist, Geriatrician and so on so forth. We will continue to contribute to these specialty areas. By enhancing these activities we do believe we can certainly dedicate to Thailand people’s happy life with demonstrating our strong points in these therapeutic areas, which are supposed to increase in Thailand in the future.
In alignment with our mission, we have identified "Core Values and Commitments" as the basis for an attitude of cooperation and proper value judgments and as the criteria for our business activities and decision making. In addition, we have established the DAIICHI SANKYO Group Corporate Conduct Charter to act with the highest ethical standards and a good social conscience appropriate for a company engaged in a business that affects human lives.
Daiichi Sankyo (Thailand) will continue pursuing our important duties by allying with local authorities, partners and aim to be widely recognized as a Daiichi Sankyo member of “Global Pharma Innovator” in Thailand.
1. To create innovative medicines changing SOC*1
*1 SOC (Standard of Care) : Universally applied best treatment practice in today’s medical science
2. To take a global perspective, and respect regional values
3. To foster intellectual curiosity and strategic insight
4. To provide the highest quality medical information
5. To provide a stable supply of top-quality pharmaceutical products
6. To be an ethical, trusted, and respectful partner
7. To be accountable for achieving our goals
8. To demonstrate professionalism, respect for others and teamwork
DSTH vision : “Contribute to Thailand people’s happy life with demonstrating our strong points in infectious, cardiovascular and pain field through the provision of pharmaceuticals addressing diverse medical needs and enriched regional value products aligned with regional market needs”